These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Drug eruptions due to meprobamate. STROUD GM N Engl J Med; 1957 Feb; 256(8):354-5. PubMed ID: 13419002 [No Abstract] [Full Text] [Related]
23. [Effect of meprobamate and emylcamate on human performance in a prolonged serial task]. BERTELSON P; JOFFE R Psychopharmacologia; 1962 Oct; 3():242-53. PubMed ID: 13966735 [No Abstract] [Full Text] [Related]
24. Induction of increased meprobamate metabolism in rats pretreated with some neurotropic drugs. KATO R; VASSANELLI P Biochem Pharmacol; 1962 Aug; 11():779-94. PubMed ID: 14454291 [No Abstract] [Full Text] [Related]
25. Adverse reactions to meprobamate. FRIEDMAN HT; MARMELZAT WL J Am Med Assoc; 1956 Oct; 162(7):628-30. PubMed ID: 13366645 [No Abstract] [Full Text] [Related]
26. Fatal reaction following the ingestion of meprobamate. ADLIN EV; SHER PB; BERK NG AMA Arch Intern Med; 1958 Sep; 102(3):484-9. PubMed ID: 13570739 [No Abstract] [Full Text] [Related]
27. Meprobamate reaction. LEVAN NE AMA Arch Derm; 1957 Mar; 75(3):437-8. PubMed ID: 13402219 [No Abstract] [Full Text] [Related]
28. A comparison of meprospan (sustained action meprobamate capsule) with other tranquilizing and relaxing agents in children. BAIRD HW J Pediatr; 1959 Feb; 54(2):170-5. PubMed ID: 13621363 [No Abstract] [Full Text] [Related]
29. Meprobamate and other agents used in mental disturbances; concluding remarks. GERARD RW Ann N Y Acad Sci; 1957 May; 67(10):885-94. PubMed ID: 13459160 [No Abstract] [Full Text] [Related]
30. [10 cases of anaphylactic shock caused by various drugs]. Beliaeva NV Ter Arkh; 1967 Feb; 39(2):113-5. PubMed ID: 5611682 [No Abstract] [Full Text] [Related]
31. [DRUGS AND WOMEN DURING THE CHILD-BEARING AGE]. KULLANDER S; KAELLEN B Bull Schweiz Akad Med Wiss; 1964 Sep; 20():571-84. PubMed ID: 14192397 [No Abstract] [Full Text] [Related]
32. Meprobamate and other agents used in mental disturbances; introductory remarks. BECKMAN H Ann N Y Acad Sci; 1957 May; 67(10):673-4. PubMed ID: 13459137 [No Abstract] [Full Text] [Related]
33. [STUDY OF THE HYPNOTIC POWER OF A NEW THERAPEUTIC COMBINATION: MEPROBAMATE-CB 1664]. LEBLOIS J Lille Med; 1964 Jan; 9():88-9. PubMed ID: 14124119 [No Abstract] [Full Text] [Related]
34. Tranquilizing drugs and the generalist. HOLLISTER LE Med Times; 1956 Oct; 84(10):1021-6. PubMed ID: 13368866 [No Abstract] [Full Text] [Related]
35. Use of tranquilizers in diseases of the skin; a preliminary report. LEVAN P; WRIGHT ET Calif Med; 1956 Aug; 85(2):87-8. PubMed ID: 13343012 [TBL] [Abstract][Full Text] [Related]
36. Some observations on a sedative and a tranquilizing agent. SCHEIFLEY CH Proc Staff Meet Mayo Clin; 1959 Aug; 34():408-19. PubMed ID: 14442580 [No Abstract] [Full Text] [Related]
37. [Therapeutic study of the combination of meprobamate with current neuroleptics]. DUC N; MONNIER A; BERGONIER J Rev Med Fr; 1960 Apr; 41():299-301. PubMed ID: 24546482 [No Abstract] [Full Text] [Related]
38. A CONTROLLED STUDY OF 4-(1-PHENYL-4-PIPERAZINYL)-BUTYL 3,4,5-TRIMETHOXYBENZATE HYDROCHLORIDE (MA 568) AND MEPROBAMATE IN PSYCHIATRIC OUTPATIENTS. JANECEK J; SCHIELE BC; BELLVILLE TP; VESTRE ND J New Drugs; 1965; 5(1):51-6. PubMed ID: 14283068 [No Abstract] [Full Text] [Related]
39. A comparative clinical study of meprobamate and chlordiazepoxide. PENNINGTON VM Med Times; 1962 Aug; 90():841-6. PubMed ID: 14485129 [No Abstract] [Full Text] [Related]